All articles by

• 

  Genprex links with University of Michigan on lung cancer treatment

  Genprex has entered an exclusive licensing agreement with the US University of Michigan for lung cancer therapy, Reqorsa. The company…

• 

  Kura Oncology partners Kyowa Kirin to advance AML treatment

  Kura Oncology has partnered Kyowa Kirin in a strategic global collaboration to develop and commercialise oral ziftomenib, an investigational menin…

• 

  EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia

  The European Commission (EC) has granted marketing authorisation for Pfizer's anti-tissue factor pathway inhibitor (anti-TFPI), HYMPAVZI (marstacimab), to treat prophylaxis…

• 

  Tris Pharma receives ex-US approvals for ADHD treatments

  Tris Pharma has received additional ex-US approvals for its attention deficit hyperactivity disorder (ADHD) treatments, Quillivant XR and QuilliChew ER.…

• 

  Pharmanovia signs license agreement for Lindis Biotech’s catumaxomab

  Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialise catumaxomab, a new trifunctional bi-specific monoclonal antibody treatment for…